BES, a leader in the design and construction of sophisticated environments for the pharmaceutical sector, has completed a viral vector suite facility for Cobra Biologics, a biologics specialist at the forefront of Covid-19 vaccine scale-up and manufacturing.
Located within Keele University campus, the time-critical project is a pivotal element of the company’s commercial strategy and BES has delivered the project four weeks ahead of schedule, despite the social distancing and supply chain challenges of the Covid-19 pandemic.
The refurbishment project involved design and delivery of three grade C processing suites, each specified to contain a class 2 microbiological safety cabinet (MBSC), which will allow biological manipulations to be carried out in a grade A environment.
Scientists will enter the new facilities via a primary change area to gain access to a grade C change area. Processing suites will be accessed via a clean corridor and exited into a ‘dirty’ corridor that leads back to the primary change area.
Peter Coleman, CEO of Cobra, commented: “It’s extraordinary that, despite the challenges of the lockdown, BES has completed the project to such a high standard ahead of schedule.”
